PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 29 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
A combination of ivy (Hedera helix L.), primrose (Primula veris L./Primula elatior L.), and thyme (Thymus vulgaris L./Thymus zygis L.) has promising clinical effects, although mechanistic evidence is lacking [PMID:37765014].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 37765014 (2023) — Mechanistic Evidence of Andrographis paniculata (Burm. f.) Wall. ex Nees, Pelargonium sidoides DC., Echinacea Species and a Combination of Hedera helix L., Primula veris L./Primula elatior L. and Thymus vulgaris L./Thymus zygis L. in the Treatment of Acute, Uncomplicated Respiratory Tract Infections: A Systematic Literature Review and Expert Interviews. · Pharmaceuticals (Basel, Switzerland)
- 2.PMID: 28835753 (2017) — Phenolics in Primula veris L. and P. elatior (L.) Hill Raw Materials. · International journal of analytical chemistry
- 3.PMID: 16297921 (2006) — Analysis of phenolic glycosides and saponins in Primula elatior and Primula veris (primula root) by liquid chromatography, evaporative light scattering detection and mass spectrometry. · Journal of chromatography. A
- 4.PMID: 11783589 (2001) — Triterpenoid saponin from Primula elatior subsp. meyeri. · Journal of Asian natural products research
- 5.